Renal Cell Carcinoma
JAMA Clinical Reviews
00:00
Advancements in Stage 4 Metastatic Kidney Cancer Treatment
This chapter explores the transition from ineffective chemotherapy to targeted therapies and immunotherapy for patients with stage 4 metastatic kidney cancer. It highlights the significance of personalized treatment approaches based on molecular characteristics and patient prognosis for improved long-term survival outcomes.
Transcript
Play full episode
